Document is current
Any future updates will be listed below
-
Authors
Shankar, Rohit https://orcid.org/0000-0002-1183-6933
Marston, Xiaocong Li https://orcid.org/0000-0002-0025-8197
Danielson, Vanessa https://orcid.org/0000-0001-5857-6254
Do Rego, Bronwyn https://orcid.org/0009-0000-1801-6228
Lasagne, Reginald https://orcid.org/0009-0003-9280-6342
Williams, Oliver https://orcid.org/0009-0006-7761-1389
Groves, Lara https://orcid.org/0000-0002-9577-1021
-
Funding
Funding for this research was provided by:
LivaNova
- License Information
-
More Information
Article History
Received: 13 November 2023
Revised: 14 December 2023
Accepted: 19 December 2023
First Online: 19 January 2024
Declarations
:
: RS has received institutional and research support from LivaNova, UCB, Eisai, Veriton Pharma, Bial, Angelini, UnEEG and Jazz/GW pharma outside the submitted work. He holds grants from NIHR AI, SBRI and other funding bodies all outside this work. VD, BDR, RL, and OW were employees of LivaNova at the time of the study and manuscript submission. XLM and LG were employees of OPEN Health at the time of the study and manuscript submission, who received consulting fees from LivaNova.
: The study is a retrospective observational study. Only de-identified secondary data were used for the study. Approval of the study was obtained from the data governance framework for the Clinical Practice Research Datalink, underpinned by the Research Data Governance process (Protocol Reference ID: 22_002201).
: Not applicable for a retrospective observational study.
